phenytoin and tacrolimus

phenytoin has been researched along with tacrolimus in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (9.52)18.2507
2000's5 (23.81)29.6817
2010's7 (33.33)24.3611
2020's7 (33.33)2.80

Authors

AuthorsStudies
Andricopulo, AD; Moda, TL; Montanari, CA1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Mosley, CA; Thompson, PA1
Andres, A; Carreño, A; Cubas, A; Delgado, M; Dominguez-Gil, B; Herrero, JC; Latorre, A; Manzanares, C; Morales, E; Morales, JM; Moreno, M1
Arriba, L; de Andrés, A; Hernández, G; Lucas, M1
Evans, CG; Formea, CM; Karlix, JL1
Koike, H; Oki, Y; Sobue, G1
Hanatani, A; Kotake, T; Morishita, H; Nakatani, T; Ochi, H; Takada, M; Ueda, T; Wada, K1
Matsumoto, H; Ugawa, Y1
Bax, K; Filler, G; Rieder, MJ; Tijssen, J1
Hamid, M; McGowan, M; Meaney, CJ; O'Connor, M; Su, W1
Asch, WS; Belfield, KD; Cohen, EA; Harkness, TM1
Inany, M; Lee, SJ; Sharma, A; Wahby, KA1
Bernard, SA; Boilson, BA; Lemke, AI; Razonable, RR1
Carroll, E; McCabe, D; Sindelar, M2
da Silva Dal Pizzol, T; de Oliveira, LM1

Reviews

4 review(s) available for phenytoin and tacrolimus

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Reduction of severe gingival overgrowth in a kidney transplant patient by replacing cyclosporin A with tacrolimus.
    Journal of periodontology, 2000, Volume: 71, Issue:10

    Topics: Anticonvulsants; Cyclosporine; Drug Synergism; Drug Therapy, Combination; Epilepsy; Female; Gingival Overgrowth; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Phenytoin; Tacrolimus; Time Factors

2000
Altered cytochrome p450 metabolism of calcineurin inhibitors: case report and review of the literature.
    Pharmacotherapy, 2005, Volume: 25, Issue:7

    Topics: Adult; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Cytochrome P-450 CYP3A; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Oxidoreductases, N-Demethylating; Phenytoin; Tacrolimus

2005
[Adverse effects of therapeutic drugs on peripheral nervous system].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2007, Aug-10, Volume: 96, Issue:8

    Topics: Anti-HIV Agents; Anticonvulsants; Antineoplastic Agents; Antitubercular Agents; Cisplatin; Dose-Response Relationship, Drug; Early Diagnosis; Humans; Immunosuppressive Agents; Paclitaxel; Peripheral Nervous System Diseases; Phenytoin; Tacrolimus; Thalidomide; Vincristine

2007

Other Studies

17 other study(ies) available for phenytoin and tacrolimus

ArticleYear
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Tacrolimus-phenytoin interaction.
    The Annals of pharmacotherapy, 1996, Volume: 30, Issue:5

    Topics: Dose-Response Relationship, Drug; Drug Interactions; Humans; Male; Middle Aged; Phenytoin; Tacrolimus

1996
Clinical management of tacrolimus drug interactions in renal transplant patients.
    Transplantation proceedings, 1999, Volume: 31, Issue:6

    Topics: Adult; Aged; Antifungal Agents; Candidiasis; Drug Interactions; Erythromycin; Female; Humans; Immunosuppressive Agents; Ketoconazole; Kidney Transplantation; Male; Phenytoin; Postoperative Complications; Rifampin; Tacrolimus

1999
Drug interactions between tacrolimus and phenytoin in Japanese heart transplant recipients: 2 case reports.
    International journal of clinical pharmacology and therapeutics, 2007, Volume: 45, Issue:9

    Topics: Adult; Anticonvulsants; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Japan; Phenytoin; Tacrolimus

2007
[Drug induced peripheral neuropathy].
    Nihon rinsho. Japanese journal of clinical medicine, 2012, Volume: 70 Suppl 6

    Topics: Amiodarone; Anti-Arrhythmia Agents; Anti-HIV Agents; Antibodies, Monoclonal; Anticonvulsants; Antineoplastic Agents; Antiprotozoal Agents; Antirheumatic Agents; Antitubercular Agents; Colchicine; Gout Suppressants; Humans; Immunosuppressive Agents; Infliximab; Interferon-alpha; Metronidazole; Peripheral Nervous System Diseases; Phenytoin; Tacrolimus

2012
Rapid resolution of tacrolimus intoxication-induced AKI with a corticosteroid and phenytoin.
    The Annals of pharmacotherapy, 2014, Volume: 48, Issue:11

    Topics: Child; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Transplantation; Methylprednisolone; Phenytoin; Tacrolimus

2014
Treatment of prolonged tacrolimus toxicity using phenytoin in a haemodialysis patient.
    Journal of clinical pharmacy and therapeutics, 2019, Volume: 44, Issue:4

    Topics: Darunavir; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Humans; Immunosuppressive Agents; Male; Middle Aged; Phenytoin; Renal Dialysis; Ritonavir; Tacrolimus

2019
Clinical Implications of Unique Drug Interaction Between Extended Release Tacrolimus and Phenytoin.
    Progress in transplantation (Aliso Viejo, Calif.), 2020, Volume: 30, Issue:2

    Topics: Anticonvulsants; Calcineurin Inhibitors; Delayed-Action Preparations; Drug Interactions; Female; Graft Rejection; Humans; Kidney Transplantation; Middle Aged; Phenytoin; Tacrolimus

2020
Use of phenytoin for treatment of tacrolimus toxicity with superimposed sepsis.
    BMJ case reports, 2020, Jul-20, Volume: 13, Issue:7

    Topics: Adult; Cytochrome P-450 CYP1A2 Inducers; Female; Humans; Immunosuppressive Agents; Phenytoin; Sepsis; Tacrolimus; Treatment Outcome

2020
Phenytoin to expedite sirolimus and tacrolimus elimination.
    Clinical transplantation, 2022, Volume: 36, Issue:12

    Topics: Humans; Immunosuppressive Agents; Kidney Transplantation; Phenytoin; Sirolimus; Tacrolimus

2022
Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin.
    Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2023, Volume: 19, Issue:1

    Topics: Aged; COVID-19; COVID-19 Drug Treatment; Drug Interactions; Female; Humans; Phenytoin; Ritonavir; SARS-CoV-2; Tacrolimus

2023
Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin".
    Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2023, Volume: 19, Issue:3

    Topics: Humans; Phenytoin; Ritonavir; Tacrolimus

2023
Response to Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin".
    Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2023, Volume: 19, Issue:3

    Topics: Humans; Phenytoin; Ritonavir; Tacrolimus

2023